Diseases, Conditions, Syndromes
Boceprevir: Indication of added benefit for specific patients
The active ingredient boceprevir has been available since the middle of 2011 as a treatment for chronic hepatitis C of genotype 1. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal ...
Dec 9, 2011
0
0
